Načítá se...
Treatment of Infants Identified by Newborn Screening for Severe Combined Immunodeficiency
BACKGROUND: Severe combined immunodeficiency (SCID) is characterized by severely impaired T cell development and is fatal without treatment. Newborn screening (NBS) for SCID permits identification of affected infants before development of opportunistic infections and other complications. Substantial...
Uloženo v:
| Vydáno v: | J Allergy Clin Immunol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5385855/ https://ncbi.nlm.nih.gov/pubmed/28270365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2017.01.005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|